Search Results 191-200 of 845 for Zepbound
Abdelaziz RM, Faldu P, Fathima S, Zepeda Mendoza CJ, Pardanani A, He R, Orazi A, Reichard KK, Gangat N, Tefferi A. Myeloproliferative ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
Garg P, Alomari M, Wadiwala I, Lyle M, Pham S, Celik NB, Moreno JCL, Goswami R, Landolfo K, Nativi-Nicolau J, Yip D, Patel PC, Sareyyupoglu B. High profile ...
This includes: 1) FAP related disease progression indicating the need for excisional intervention involving the colon, rectum, pouch, duodenum and/or 2) ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
The purpose of this study is to compare the effect of benralizumab 30 mg every 4 weeks (Q4W) with placebo on histologic signs and gastrointestinal symptoms in ...
A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy ...
Muscle overactivity can be a side effect of spinal cord injury or illness. Treatment may include physical therapy, medicine or surgery.
Nosebleeds involve bleeding from inside the nose. Many people have nosebleeds once in a while. They tend to be more common in children younger than 10 and ...
Publications · Khoja IT, Peck DS, Gavrilov DK, McPheron MA, Oglesbee D, Bentz Pino G, Sapp KL, Schultz MJ, Studinski Jones AL, White AL, Tortorelli S, Matern D, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.